Bioanalytical method validation to quantify ketorolac in human vitreous and aqueous via surrogate matrix of human plasma

The validated method can use plasma as a surrogate matrix for quantitation of ketorolac in aqueous and vitreous humor, thereby eliminating the need to procure human vitreous and aqueous samples for validation prior to initiation of a clinical trial.